Barisione Chiara, Charnigo Richard, Howatt Deborah A, Moorleghen Jessica J, Rateri Debra L, Daugherty Alan
Cardiovascular Research Center, University of Kentucky, Lexington, KY 40536, USA.
J Vasc Surg. 2006 Aug;44(2):372-6. doi: 10.1016/j.jvs.2006.04.047.
Infusion of angiotensin II (AngII) via subcutaneous osmotic pumps into mice promotes the development of abdominal aortic aneurysms (AAAs). These AngII-induced AAAs develop via a complex process in which there is a transmedial break, lumen dilation, thrombus formation, inflammation involving cells of both the innate and acquired immune systems, and remodeling. The recent development of a high-frequency ultrasound machine has permitted the noninvasive detection of murine abdominal aortas. We assessed the ability of a Visualsonics Vevo 660 high-resolution imaging system to detect AAAs and sequentially quantify the aortic luminal diameter. This system had 100% accuracy in detecting AngII-induced AAAs in vivo, with intrauser and interuser variation coefficients of less than 10% for quantification of the aortic lumen diameter.
Male apolipoprotein E (apoE)(-/-) mice were infused subcutaneously with either saline or AngII and were monitored with this ultrasonic system to define the temporal changes in aortic lumen diameter. Aortic luminal diameters were measured in the aneurysm-susceptible region of the suprarenal aorta. For internal controls, abdominal aortic diameters were measured at the level of the left renal branch, because this landmark region did not dilate during AngII infusion.
Luminal diameters of the suprarenal aorta did not change significantly in saline-infused mice over 28 days of measurement (P = .71). In contrast, AngII infusion led to rapid dilation of suprarenal aortas during the initial 7 days of infusion (0.071 mm/d; P = .0037 for the change in the initial expansion rate). Further luminal diameter expansions occurred for the remaining 21 days of observation at a more modest rate (0.023 mm/d; P = .0001 for continued expansion after day 7). Within the initial 14 days of AngII infusion, some apoE(-/-) mice died as a result of rupture of the aorta in the suprarenal region. We had previously assumed that aortic dilation and rupture occurred simultaneously. However, in the AngII-infused mice that succumbed to aortic rupture, luminal diameters increased several days before death.
High-frequency ultrasonography demonstrated that suprarenal aortic expansion occurs rapidly after the initiation of AngII infusion into apoE(-/-) mice.
通过皮下渗透泵向小鼠输注血管紧张素II(AngII)可促进腹主动脉瘤(AAA)的发展。这些由AngII诱导的AAA通过一个复杂的过程发展,包括跨中膜破裂、管腔扩张、血栓形成、涉及先天和后天免疫系统细胞的炎症以及重塑。高频超声仪的最新发展使得对小鼠腹主动脉进行无创检测成为可能。我们评估了Visualsonics Vevo 660高分辨率成像系统检测AAA并顺序量化主动脉管腔直径的能力。该系统在体内检测AngII诱导的AAA时准确率为100%,在量化主动脉管腔直径时,用户内和用户间变异系数均小于10%。
雄性载脂蛋白E(apoE)基因敲除(apoE(-/-))小鼠皮下注射生理盐水或AngII,并使用该超声系统进行监测,以确定主动脉管腔直径的时间变化。在肾上腺主动脉的动脉瘤易感区域测量主动脉管腔直径。作为内部对照,在左肾分支水平测量腹主动脉直径,因为在输注AngII期间该标志性区域不会扩张。
在测量的28天内,注射生理盐水的小鼠肾上腺主动脉管腔直径无显著变化(P = 0.71)。相比之下,输注AngII导致在输注的最初7天内肾上腺主动脉迅速扩张(0.071 mm/天;初始扩张率变化的P = 0.0037)。在观察的剩余21天内,管腔直径以更适度的速率进一步扩张(0.023 mm/天;第7天后持续扩张的P = 0.0001)。在输注AngII的最初14天内,一些apoE(-/-)小鼠因肾上腺区域主动脉破裂而死亡。我们之前认为主动脉扩张和破裂是同时发生的。然而,在因主动脉破裂而死亡的输注AngII的小鼠中,管腔直径在死亡前几天增加。
高频超声检查表明,在apoE(-/-)小鼠开始输注AngII后,肾上腺主动脉迅速扩张。